Six years of work by Harm Reduction Therapeutics paid off today!
The FDA has officially approved over-the-counter RiVive™ (naloxone HCl nasal spray 3 mg) for the emergency treatment of opioid overdose.
Our work is guided by harm reduction principles. We advocate for and operating under practical strategies to reducing negative consequences associated with drug use.
We are one sponsor of the Ad Council's “It’s Gotta Be You” PSA to spread naloxone education as part of the Office of National Drug Control Policy (ONDCP) fentanyl awareness campaign: https://t.co/7IIuLScr9O
We hope you’ll take a moment to learn how to use our compassionate dose FDA-approved OTC opioid overdose reversal medication, RiVive® Naloxone HCI Nasal Spray 3 mg, by watching our latest video:
We’re proud to launch our new life-saving PSAs, created by @Frogism and developed as part of our partnership with the @ONDCP. The new work encourages young people to carry and know how to use naloxone so they are prepared to save lives.
Learn more at https://t.co/CFkLxOWnm3
At HRT, we believe that over-the-counter naloxone that saves lives without creating unintended harm should not be a privilege reserved for a few; it should be a right afforded to all, especially those most at risk of losing their lives to a fatal overdose.
As a 501(c)(3) NFP, we are continuously seeking funding partners so that we may increase product donations or decrease the selling price of products for harm reduction organizations, public charities, and other local community groups. Learn how to become a funding partner today:
ReVive® Naloxone HCI Nasal Spray 3 mg is a compassionate dose naloxone product created for harm reductionist by harm reductionists. Learn how HRT is working to make naloxone available at a low-cost or free while supporting harm reduction from our founder and CEO Michael Hufford:
While the summit took place a few months ago, the importance of the discussions remains as crucial as ever. Learn more about the summit’s key highlights and takeaways: https://t.co/xjwLccVUOq
The Compassionate Overdose Response Summit hosted in March discussed best practices in overdose prevention and engaged participants in a dialogue about naloxone dosing.
Remedy Alliance/For the People: https://t.co/VcSSKpUURT
Prevention Point Pittsburgh: https://t.co/WZjRK1euiS
National Harm Reduction Coalition: https://t.co/5LmEmdvzGk
Drug Intervention Institute (DII): https://t.co/nlWFx3qehf
#GivingTuesday#NaloxoneSavesLives
In the US, harm reduction orgs support communities in reducing negative consequences associated with drug use, like increasing access to lifesaving naloxone - opioid overdose reversal meds. Help put naloxone into the hands of those most at risk by making a donation to:
RiVive® naloxone HCI nasal spray 3 mg is an FDA-approved compassionate dose naloxone product created for harm reductionists by harm reductionists, made in the USA. Learn how to use RiVive® with these 5 key steps:
Remedy Alliance/For the People: https://t.co/VcSSKpUURT
Prevention Point Pittsburgh: https://t.co/WZjRK1euiS
National Harm Reduction Coalition: https://t.co/5LmEmdvzGk
Drug Intervention Institute (DII): https://t.co/nlWFx3qehf
In the last 12 months over 81,000 people died in the US from overdoses involving opioids. Every one was preventable and each was someone who deserved a seat at the table.
Our work is guided by harm reduction principles like reducing negative consequences associated with drug use. We created RiVive® as a 3 mg naloxone product-strong enough to save lives while minimizing the unintended consequences of overdose reversal, like precipitated withdrawal.
Thanks to all who visited our booth and gave such a warm reception to FDA-approved OTC RiVive® (naloxone HCl nasal spray 3 mg), a compassionate dose emergency treatment of known or suspected opioid overdose created and made available for harm reductionists by harm reductionists.